Nature throws curveballs: APOE and nonlinear decline in Alzheimer disease

Neurology

Volumn 65, Issue 12, 2005, Pages 1855-1856

  Camicioli, Richard ^a   Kryscio, Richard ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4;

ALLELE; ALZHEIMER DISEASE; DISEASE COURSE; EDITORIAL; FOLLOW UP; GENETIC HETEROGENEITY; HUMAN; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT COUNSELING; PRIORITY JOURNAL; PROGNOSIS; BIOLOGICAL MODEL; COGNITIVE DEFECT; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; NEUROPSYCHOLOGICAL TEST; NONLINEAR SYSTEM; NOTE; PSYCHOLOGICAL ASPECT;

ALZHEIMER DISEASE; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COGNITION DISORDERS; COHORT STUDIES; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MODELS, NEUROLOGICAL; NEUROPSYCHOLOGICAL TESTS; NONLINEAR DYNAMICS; PROGNOSIS;

EID: 33645745789     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000195338.67756.4b     Document Type: Editorial

References (10)

1. Martins CAR, Oulhaj A, de Jager CA, Williams JH. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Neurology 2005;65:1888-1893.
2. Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JC, Cache County Study Investigators. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: the Cache County Study. Arch Gen Psychiatry 2004;61:518-524.
3. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Berry-Kravis E, Arnold SE. Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people. J Neurol Neurosurg Psychiatry 2005;76:1194-1199.
4. Laupacis A, Wells G, Richardson WS, Tugwell P, for the Evidence Based Working Group. Users' guide to the medical literature: V. How to use an article about prognosis. JAMA 272:234-237.
5. Mohs RC, Smeidker J, Aryan M. Longitudinal studies of cognitive, functional and behavioral change in patients with Alzheimer's disease. Statist Med 2000;19:1401-1409.
6. Galasko DR, Gould RL, Abramson IS, Salmon DP. Measuring change in a cohort of patients with Alzheimer's disease. Statist Med 2000;19:1421-1432.
7. Stern Y, Liu X, Albert M, et al. Application of growth curve approach to modeling the progression of Alzheimer's disease. J Gerontol 1996;51A:M179-M184.
8. Wild KV, Kaye JA. The rate of progression of Alzheimer's disease in the later stages: evidence from the severe impairment battery. J Int Neuropsychol Soc 1998;4:512-516.
9. Kaye JA, Moore MM, Dame A, et al. Asynchronous regional brain volume losses in presymptomatic to moderate AD. J Alzheimers Dis 2005;8:51-56.
10. Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Arch Neurol 2005;62:454-459.